welcome to DuchenneXchange
- a positively charged Duchenne muscular dystrophy community.- join today!
- log in
Small Molecule Therapies
Muscular dystrophy is the name given to a group of inherited diseases characterized by progressive muscle weakness and wasting. Current therapies can help manage the symptoms of the disease, and slow down its progression, but cannot cure it. However, there are several experimental treatments such as small molecule therapies that are being investigated and have the potential to vastly improve the symptoms.
Small molecules are compounds with low molecular weights that can easily enter cells and directly affect the target, which may be a protein or other molecules within the cell. More than 90% of the therapeutics made today are small molecules.
Some of the small molecules being studied as potential muscular dystrophy therapies are summarized below, grouped by their mechanism of action.
other Duchenne content
-
Pharmacokinetic Properties of Chronic Administration of Eteplirsen in the Treatment of Boys with Duchenne Muscular D...Objective: The objective of this analys...
-
Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open...Background: Drisapersen induces exon 51...
-
Safety Study of BLS-M22 in Healthy VolunteersBLS-M22 is being developed as an anti-my...
-
Duchenne Muscular Dystrophy (DMD) Therapy Treatmenthttps://www.youtube.com/watch?v=6yUq5t0x...
-
Restoring Dystrophin Expression in Duchenne Muscular Dystrophy: Current Status of Therapeutic ApproachesDuchenne muscular dystrophy (DMD), a rar...
-
Capricor places Duchenne drug trial on holdCapricor Therapeutics Inc said on Wednes...
-
Tom’s Story – Duchenne muscular dystrophy – Action Medical Researchhttps://www.youtube.com/watch?v=VWL2oGDe...
